GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Clinical trial NCT00261352 · TERMINATED

Trial details

NCT number: NCT00261352
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2005-03-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.